{"organizations": [], "uuid": "70efb76e288b1db800f6a76d1dabc6895f0e6a37", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180222.html", "section_title": "Archive News &amp; Video for Thursday, 22 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-regis-healthcare-says-hy-net-profi/brief-regis-healthcare-says-hy-net-profit-attributable-27-9-mln-idUSFWN1QC1BM", "country": "US", "domain_rank": 408, "title": "BRIEF-Regis Healthcare Says HY ‍Net Profit Attributable $27.9 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.954, "site_type": "news", "published": "2018-02-23T06:17:00.000+02:00", "replies_count": 0, "uuid": "70efb76e288b1db800f6a76d1dabc6895f0e6a37"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-regis-healthcare-says-hy-net-profi/brief-regis-healthcare-says-hy-net-profit-attributable-27-9-mln-idUSFWN1QC1BM", "ord_in_thread": 0, "title": "BRIEF-Regis Healthcare Says HY ‍Net Profit Attributable $27.9 Mln", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "regis healthcare ltd", "sentiment": "negative"}, {"name": "ebitda", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 23 (Reuters) - Regis Healthcare Ltd:\n* INTERIM DIVIDEND 9.28 CENTS PER SECURITY * HY ‍REVENUE FROM ORDINARY ACTIVITIES $297 MILLION, UP 4%​\n* HY ‍NET PROFIT ATTRIBUTABLE TO MEMBERS $27.9 MILLION, DOWN 12 PERCENT\n* ‍ANTICIPATES 2H FY18 NORMALISED EBITDA TO BE BROADLY IN LINE WITH 1H FY18 NORMALISED EBITDA RESULT​‍​\n* FY18 NORMALISED NPAT IS ANTICIPATED TO BE IN RANGE OF $56M TO $58M Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-23T06:17:00.000+02:00", "crawled": "2018-02-23T15:51:33.000+02:00", "highlightTitle": ""}